Evidence map›Paper›PMID 40368984›Full record

ArticleNature communications2025

Persistent acyclic Cp*Ir(III) complexes and their reactivities in cross-coupling reactions.

Yimin Wu, Yayin Deng, Guangying Tan, Jingsong You

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yimin WuKey Laboratory of Green Chemistry and Technology of Ministry of Education, College of Chemistry, Sichuan University, Chengdu, 610064, People's Republic of China.
Yayin DengKey Laboratory of Green Chemistry and Technology of Ministry of Education, College of Chemistry, Sichuan University, Chengdu, 610064, People's Republic of China.
Guangying TanKey Laboratory of Green Chemistry and Technology of Ministry of Education, College of Chemistry, Sichuan University, Chengdu, 610064, People's Republic of China. guangying@scu.edu.cn.ORCID http://orcid.org/0000-0003-3648-8039
Jingsong YouKey Laboratory of Green Chemistry and Technology of Ministry of Education, College of Chemistry, Sichuan University, Chengdu, 610064, People's Republic of China. jsyou@scu.edu.cn.ORCID http://orcid.org/0000-0002-0493-2388

Funding

National Natural Science Foundation of China (National Science Foundation of China) 22031007National Natural Science Foundation of China (National Science Foundation of China) 22401200
6 · The paper itself

Abstract

Iridium(III) complexes play a prominent role in organometallic chemistry, with significant research efforts directed toward Cp*Ir(III) species, broadly categorized into cyclic and acyclic types. Although studies on these two classes began roughly simultaneously, the development of acyclic Cp*Ir(III) complexes has lagged significantly behind their cyclic counterparts. Herein, we report a general and efficient strategy for synthesizing various persistent aryl Cp*Ir(III)(CO)Cl complexes directly from aryl aldehydes, with in situ generated CO as a stabilizing ligand. These acyclic Cp*Ir(III) complexes showcase exceptional reactivity, undergoing reactions with up to eight classes of nucleophiles to generate diverse diorganoiridium(III) species with remarkable stability. Electrochemical analysis of these complexes provides insights into their reductive elimination processes. Guided by these findings, Cp*Ir(III)-mediated decarbonylative C-C and C-O cross-couplings of aryl aldehydes are successfully developed. This study establishes a robust platform for the exploration of acyclic Cp*Ir(III) complexes, paving the way for further advancements in iridium(III) chemistry.

Identifiers

PMID40368984
PMCPMC12078468

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.